Aberrant expression of CD7 in acute myeloid leukemias with FLT3-ITD

被引：0
|
作者：
Junca, Jordi [1 ]
Zamora, Lurdes [1 ]
Cabezon, Marta [1 ]
Marce, Silvia [1 ]
Nomdedeu, Josep [2 ]
机构：
[1] Hosp Badalona Germans Trias & Pujol, Dept Hematol, Barcelona, Spain
[2] Hosp Santa Creu & Sant Pau, Dept Hematol, Barcelona, Spain
来源：
AMERICAN JOURNAL OF CLINICAL PATHOLOGY | 2008年 / 130卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：644 / 644
页数：1
相关论文
共 50 条
  • [31] Targeting BTK for the treatment of FLT3-ITD mutated acute myeloid leukemia
    Genevra Pillinger
    Amina Abdul-Aziz
    Lyubov Zaitseva
    Matthew Lawes
    David J. MacEwan
    Kristian M. Bowles
    Stuart A. Rushworth
    Scientific Reports, 5
  • [32] Prognostic Value of FLT3-ITD Residual Disease in Acute Myeloid Leukemia
    Vonk, Christian
    Grob, Tim
    Sanders, Mathijs
    Kavelaars, Francois
    Rijken, Melissa
    Hanekamp, Diana
    Gradowska, Patrycja
    Cloos, Jaqueline
    Floisand, Yngvar
    Kooy, Marinus Van Marwijk
    Manz, Markus
    Ossenkoppele, Gert
    Tick, Lidwine
    Vekemans, Marie-Christiane
    Lowenberg, Bob
    Jongen-Lavrencic, Mojca
    Valk, Peter
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S227 - S227
  • [33] FLT3-ITD As a Prognostic Factor for Chinese Patients with Acute Myeloid Leukemia
    Sun, Jie
    He, Jingsong
    Wei, Guoqing
    Zheng, Weiyan
    Shi, Jimin
    Luo, Yi
    Huang, He
    BLOOD, 2016, 128 (22)
  • [34] FLT3-ITD regulation of the endoplasmic reticulum functions in acute myeloid leukemia
    Turos-Cabal, Maria
    Sanchez-Sanchez, Ana M.
    Puente-Moncada, Noelia
    Herrera, Federico
    Antolin, Isaac
    Rodriguez, Carmen
    Martin, Vanesa
    HEMATOLOGICAL ONCOLOGY, 2024, 42 (03)
  • [35] Pitfalls in molecular standardization for detection of FLT3-ITD in acute myeloid leukemia
    da Costa, Juliana B.
    Naressi, Rafaella G.
    Ramires, Jordana
    Vianna, Danielle T.
    Teles, Juliana A.
    Padilha, Telma F.
    Monte-Mor, Barbara da C. R.
    Zalcberg, Ilana
    Gutiyama, Luciana M.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2023, 45 (04) : 581 - 585
  • [36] Targeting BTK for the treatment of FLT3-ITD mutated acute myeloid leukemia
    Pillinger, Genevra
    Abdul-Aziz, Amina
    Zaitseva, Lyubov
    Lawes, Matthew
    MacEwan, David J.
    Bowles, Kristian M.
    Rushworth, Stuart A.
    SCIENTIFIC REPORTS, 2015, 5
  • [37] A model for prediction of FLT3-ITD and NPM1 (without FLT3-ITD) positivity in patients with newly diagnosed acute myeloid leukaemia
    Ostronoff, Fabiana
    Othus, Megan
    Kantarjian, Hagop M.
    Meshinchi, Soheil
    Ravandi, Farhad
    Hendrie, Paul C.
    Faderl, Stefan
    Becker, Pamela S.
    Cortes, Jorge E.
    Pagel, John M.
    Petersdorf, Stephen H.
    Godwin, John E.
    Willman, Cheryl L.
    Pierce, Sherry A.
    List, Alan F.
    Sandhu, Ravinder K.
    Walter, Roland B.
    Stirewalt, Derek L.
    Appelbaum, Frederick R.
    Estey, Elihu H.
    BRITISH JOURNAL OF HAEMATOLOGY, 2013, 163 (01) : 130 - 132
  • [38] RSK1 dependency in FLT3-ITD acute myeloid leukemia
    Kong, Tim
    Laranjeira, Angelo B. A.
    Letson, Christopher T.
    Yu, Layow
    He, Fan
    Jayanthan, Aarthi
    Los, Gerrit
    Dunn, Sandra E.
    Challen, Grant A.
    Oh, Stephen T.
    BLOOD CANCER JOURNAL, 2024, 14 (01):
  • [39] Influence of FLT3-ITD Mutation and Length on the Prognosis in Acute Myeloid Leukemia
    Jiang, Xuejie
    Chen, Fang
    Yin, Changxin
    Jiang, Ling
    Yu, Guo-Pan
    Xu, Dan
    Sun, Jing
    Liu, Xiaoli
    Liu, Qifa
    BLOOD, 2017, 130
  • [40] Molecular analysis of different FLT3-ITD mutations in acute myeloid leukemia
    Blau, Olga
    Berenstein, Rimma
    Sindram, Annette
    Blau, Igor Wolfgang
    LEUKEMIA & LYMPHOMA, 2013, 54 (01) : 145 - 152
12345